- Case-Based Roundtable
- General Dermatology
- Eczema
- Chronic Hand Eczema
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
- Prurigo Nodularis
- Buy-and-Bill
News
Article
The Future of AI in Dermatology with Andy Beck, MD, PhD
Key Takeaways
- AI enhances dermatology by improving the evaluation of complex patterns and diagnostic accuracy, leading to better patient outcomes.
- PathAssist Derm assists dermatopathologists in diagnosing skin cancers, ensuring more accurate, reproducible, and efficient diagnoses.
The co-founder of PathAI and its PathAssist Derm tool believes AI is going to be incredibly valuable for dermatologists and dermatopathologists.
“AI is going to be an incredibly valuable technique for dermatologists and dermatopathologists, because so much of the work that both do is evaluating complex patterns, particularly seeing how those complex patterns change over time,” said Andy Beck, MD, PhD, CEO and co-founder of PathAI.
In a previous interview with Dermatology Times, Beck discussed the development of the PathAssist Derm tool, which can assist dermatopathologists in diagnosing skin cancers. The company’s latest technology will have a positive impact on patient outcomes and the future of dermatologic care.
Beck highlighted the importance of accurate dermatopathology diagnoses, as it guides treatment decisions for patients with skin diseases. According to Beck, the use of artificial intelligence can ensure more accurate, reproducible, and efficient diagnoses, ultimately improving patient care by enabling quicker, more precise treatment recommendations following skin biopsies.
Beck also shared his vision for the future of PathAssist Derm. This initial research version of the tool is a significant advancement in AI technology for dermatology and he is eager for investigators to test the tool’s effectiveness and impact in clinical settings. He hopes these studies will validate its ability to improve diagnostic accuracy and accelerate the pace of dermatologic research.
Looking forward, Beck discussed AI’s growing role in dermatologic care. He sees a future where patients can routinely scan their skin at home using AI technology to track lesion changes and receive alerts if any lesions require professional care. Following in-person evaluation and clinical biopsy, digital pathology systems, supported by AI tools like PathAssist Derm, could further ensure accurate diagnoses and recommend appropriate treatments.
“I think AI plays a critical role in every step that I just mentioned, and I'm sure that will be the future of dermatologic care,” Beck concluded. “So, I think automating a lot of these things, and observing subtle changes over time will be very important.”
PathAssist Derm is available on the AISight® Image Management System. Users can schedule a free demo with the PathAI team by emailing digitaldx@pathai.com.
